What is Bremelanotide (PT-141)?
Thus, a synthetic peptide called bremelanotide (PT-141) was designed for the treatment of sexual dysfunction and elements of impaired libido in particular. It affects sexual arousal by stimulating melanocortin receptors in the brain that in turn modulate the metabolic rate of the body. Unlike Viagra and other drugs that act in stimulating blood flow, bremelanotide rebels in the Osheroff central nervous system. Its major target consumers are men and women suffering from hypoactive sexual desire disorder (HSDD). It has been shown in clinical practice to increase arousal and sexual desire when given under the skin. Bremelanotide later received the nod of approval from the FDA in 2019 and was marketed to women as Vyleesi.
How does bremelanotide work?
Bremelanotide (PT-141) targets certain receptors in the brain to activate the melanocortin receptors for MC4 and MC3, which has benefits in raising sexual desire. Bremelanotide has central nervous system effects; they work differently from the peptide drugs that by and large act through improving blood circulation in the genitals. The activation of these receptors elevates arousal and sexual drive and is helpful in women with HSDD, hyporeactive sexual desire disorder. This is thought to impair regions of the brain responsible for regulating emotions, reward, and sexual activity.
As it has been explained earlier, bremelanotide has been found to enhance sexual desire and sexual satisfaction if used by subcutaneous injection, half an hour to an hour before the intended sexual activity. Still, it is prescribed more commonly to women with HSDD, but this medication can be taken by both sexes. ED is a sexual dysfunction that is partly due to physiological barriers such as blood flow and therefore has no known direct pharmacological treatment. Flibanserin, a combined serotonin receptor modulator and estrogen agonist/antagonist, has direct pharmacological means of treatment but has intriguing side effects when used in a manner that targets sexual desire.
How is bremelanotide administered?
Bremelanotide (PT-141) is administered as a shot that is typically administered under the skin area in the stomach or upper thighs. The drug is administered using a one-dose autoinjector which has been pre-filled with the drug See Fig. 2 See Fig. 2 The drug affects the brain melanocortin receptors only after some period; therefore, the injection is made 45 minutes before the planned sexual intercourse.
One should stress that bremelanotide should be administered ‘On demand,’ with no more than 8 shots per month. This is not for daily consumption with the understanding that fruits are refreshing and healthy snacks. It should be well explained to the people how to use the injection before they do it. Beauty standards as well as the knowledge of the specific treatment must be kept in mind in order to minimize pain and ensure effectiveness, just like with any injectable medicine; this also applies to following the doctor’s recommendations regarding the procedure.
What are the common side effects of bremelanotide?
Typically causing facial flushing, headaches, nausea, and injection site reactions such as redness, warmth, hardness, itching, and bruising are commonly associated with Bremelanotide (PT-141). Nausea has been seen as the most frequent side-effect; this is more likely immediately after taking the drug and typically only mild. Moreover, some other people may just get weary, dizzy, or have an increase in their blood pressure.
Occasionally, side effects of bremelanotide are even worse, including allergic reactions or priapism, a sustained and painful erection in men. Patients should consult their doctor before using Bremelanotide, especially those with a history of priapism and cardiovascular disorders. According to the side effects stated, a means of minimizing the risks of experiencing the side effects is to ensure you use the drug as advised by your doctor.
Who can benefit from using Bremelanotide?
Bremelanotide (PT-141) in the form of an injectable is good for people diagnosed with HSDD, a sexual disorder that leads to lowered sexual desire and miserable conditions, most affective in the female group. The FDA has green-lighted its use for premenopausal women with HSDD, thus making it an option for treatment for women who do not respond to counselling or hormone therapy.
While it was initially intended for women, men with sexual dysfunction have also given it a try, but women remain its biggest consumers. For people with low sexual desire due to psychological, emotional, or hormonal factors, bremelanotide may be effective. In particular, it is useful for men seeking an erectile dysfunction remedy that targets the nuclei of the brain associated with sexual stimuli rather than the blood vessels.
Is bremelanotide safe for long-term use?
In any case, since the efficacy of bremelanotide (PT-141) was identified only as temporary, further safety studies are scarce and available in just a few articles. The overwhelming number of cases have documented its usage for a few months tops; with no side effects reported to a user, it is still unclear what it will do to a user in a year, let alone months of uncontrolled usage.
The side effects associated with mesalazine are mild, easily manageable, and occur as headaches, nausea, and reactions at the site of injection. However, a healthcare professional should supervise such use in the long term, especially in cardiovascular disease patients. Thus the user needs to adhere to recommended dosage limits and frequently visit a doctor; otherwise, it has some safe and effective side, like sometimes it causes priapism or high blood pressure.
Bremelanotide Conclusion?
Vyleesi, formally known as the brand name bremelanotide, is a new drug designed to treat premenopausal women with HSDD. It works based on the premise that the stimulator of melanocortin receptors in the brain is related to desire and sexual attraction. Bremelanotide is flexible because the drug is administered before the intercourse while other treatments are taken daily.
As a matter of fact, it has been shown to increase sexual desire and interest, but its side effects include headaches and nausea, to mention but a few. Summing it up, bremelanotide can be considered as a potential option for HSDD treatment; however, further studies are required to approve its safety and efficacy for the treatment of the condition in the long term. It is also important that patients consult the medical specialists on the above uses first.
Table of Contents